Healthcare Services

Lung Cancer Screening Market to Reach $5.24 Billion by 2030 at 9.5% CAGR

April 23, 2026April 26, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Lung Cancer Screening Market Grow Between 2026 And 2030?

The lung cancer screening market size has seen substantial growth recently. It is anticipated to expand from $3.33 billion in 2025 to $3.65 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.6%. This historical period’s expansion is due to several factors, including the rising occurrence of lung cancer among older populations, enhanced recognition of the benefits of early screening, the expansion of diagnostic imaging facilities, continuous improvements in CT imaging technology, and the widespread adoption of screening protocols based on established guidelines.

The lung cancer screening market is projected to experience robust expansion over the next few years, reaching $5.24 billion by 2030, with a compound annual growth rate (CAGR) of 9.5%. This growth during the forecast period is driven by factors such as the rising implementation of AI-assisted diagnostic workflows, the broadening of population-based screening initiatives, an increasing emphasis on personalized risk assessment, escalating investments in early cancer detection technologies, and enhanced healthcare policy support for screening. Prominent trends anticipated in this period include the growing adoption of low-dose CT screening programs, increased integration of AI in imaging analysis, a sharpened focus on screening high-risk populations, the expansion of preventive oncology efforts, and a reinforced commitment to early lung cancer detection.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27331&type=smp

What Major Factors Are Driving The Lung Cancer Screening Market Forward?

Anticipated increases in smoking rates are expected to drive the expansion of the lung cancer screening market moving forward. Smoking is defined as the act of inhaling smoke from burning substances, typically tobacco, through the mouth and into the lungs. The rise in smoking prevalence is linked to heightened stress levels, causing more individuals to resort to smoking as a coping mechanism. Lung cancer screening plays a crucial role in addressing these rising smoking rates by enabling the early detection of smoking-related health issues, which can motivate people to quit and support broader public health efforts to reduce tobacco use. For instance, in October 2024, the Office for Health Improvement & Disparities, a UK-based government organisation, reported that the prevalence of current smokers in the routine and manual occupation group (aged 18 to 64) was 19.5% in 2023. Therefore, the increasing smoking rates are fueling the growth of the lung cancer screening market.

How Is The Lung Cancer Screening Market Segmented Across Different Segment Categories?

The lung cancer screening market covered in this report is segmented –

1) By Diagnosis Type: Low Dose Spiral Computed Tomography Scan, Chest-X-Ray

2) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer

3) By Age Group: 50 And Older, Below 50

4) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users

Subsegments:

1) By Low Dose Spiral Computed Tomography Scan: Screening, Diagnostic, Follow-Up

2) By Chest X-Ray: Posterior Anterior, Lateral, Portable

Which Trends Are Impacting The Progress Of The Lung Cancer Screening Market?

Key companies within the lung cancer screening market are concentrating on developing sophisticated tools, such as normal flagging, to improve diagnostic precision, decrease false positives, and facilitate earlier discovery of cancerous nodules. Normal flagging denotes a technological function in lung cancer screening that automatically pinpoints and marks scans without any abnormal findings, thus helping to prioritize instances that require additional review. For example, in May 2025, Lunit Inc., a medical technology company from South Korea, released INSIGHT CXR4, its subsequent generation artificial intelligence (AI)-powered chest X-ray analysis solution, which has obtained CE MDR certification for implementation across Europe. This solution, crafted to aid radiologists in achieving better diagnostic accuracy and workflow effectiveness, identifies 12 chest abnormalities, including lung nodules, pneumonia, and acute bone fractures, and integrates features like current-prior image comparison to bolster early disease detection and support clinical decision-making.

Which Organizations Play A Role In The Lung Cancer Screening Market Landscape?

Major companies operating in the lung cancer screening market are Abbott Laboratories Inc., Canon Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Quest Diagnostics Incorporated, Shimadzu Corporation, NeoGenomics Laboratories Inc., Freenome Holdings Inc., Biodesix Inc., Lunit Inc., Infervision, Riverain Technologies, VisionGate, Delfi Diagnostics Inc., Hologic Inc., Fujifilm Holdings Corporation, United Imaging Healthcare Co. Ltd., Samsung Medison Co. Ltd., Carestream Health Inc., Analogic Corporation, Toshiba Medical Systems Corporation

Get The Full Lung Cancer Screening Market Report:

https://www.thebusinessresearchcompany.com/report/lung-cancer-screening-global-market-report

Which Region Has The Greatest Market Share In The Lung Cancer Screening Market?

North America was the largest region in the lung cancer screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Lung Cancer Screening Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/lung-cancer-screening-global-market-report

Browse Through More Reports Similar to the Global Lung Cancer Screening Market 2026, By The Business Research Company

Financial Fraud Detection Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/financial-fraud-detection-software-global-market-report

Payment Monitoring Market Report

https://www.thebusinessresearchcompany.com/report/payment-monitoring-global-market-report

Ecommerce Fraud Detection And Prevention Market Report

https://www.thebusinessresearchcompany.com/report/ecommerce-fraud-detection-and-prevention-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795